Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +19.7% | +70.6% | 3 / 3 | +11.9% | +2.47 pp | +0.98 pp | +16.4% | 0.29 | 5.33 | 139 | +11,9% | 20,9 | +19,7% | 5.33 | 8.89 | −40,1% |
| Pts | 0 | 12 | 12 | 4 | 8 | 8 | 4 | 12 | 12 | |||||||
Valuation annotation:Price: 13.000 (close price on 2026-10-15)EPS (TTM): 2.441
Financial charts
1.Revenue & growth
VND bn139Q2/26
1.Revenue & growth
VND bn139Q2/26
2.Profit & growth
VND bn19,4Q2/26
3.Profit mix (Penman)
VND bn69,6Q2/26
4.Margins & cost structure
%33.2%Q2/26
5.Returns & cash cycle
% · days15.6%Q2/26
6.Earnings quality & cash
VND bn29,1Q2/26
7.Asset structure
VND bn1.104Q2/26
8.Funding & debt health
VND bn · times1.104Q2/26
9.Revenue backlog
VND bn0,36Q2/26
10.Valuation
times · %5,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %749Q2/26
Adjusted EPS growth, latest quarter
10.9%
Average adjusted EPS growth, 3 quarters
67.7%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26